• Return to Headlines

Myriad Genetics Has Returned 41.3% Since SmarTrend Recommendation (MYGN)

By James Quinn

SmarTrend identified an Uptrend for Myriad Genetics (NASDAQ:MYGN) on May 3rd, 2017 at $21.49. In approximately 4 months, Myriad Genetics has returned 41.29% as of today's recent price of $30.37.

Over the past year, Myriad Genetics has traded in a range of $15.15 to $32.97 and is now at $30.37, 100% above that low. Over the past week, the 200-day moving average (MA) has gone down 0.3% while the 50-day MA has declined 0.5%.

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Myriad Genetics shares.

Log in and add Myriad Genetics (MYGN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights myriad genetics

Ticker(s): MYGN